Found: 84
Select item for more details and to access through your institution.
Cell-cycle phases and genetic profile of bone marrow-derived mesenchymal stromal cells expanded in vitro from healthy donors.
- Published in:
- Journal of Cellular Biochemistry, 2011, v. 112, n. 7, p. 1817, doi. 10.1002/jcb.23100
- By:
- Publication type:
- Article
European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. 1062, doi. 10.1002/ajh.24837
- By:
- Publication type:
- Article
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 918, doi. 10.1002/ajh.24442
- By:
- Publication type:
- Article
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 709, doi. 10.1002/ajh.24388
- By:
- Publication type:
- Article
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 185, doi. 10.1002/ajh.23372
- By:
- Publication type:
- Article
Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 5, p. 562, doi. 10.1002/ajh.23169
- By:
- Publication type:
- Article
Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 8, p. 616, doi. 10.1002/ajh.21754
- By:
- Publication type:
- Article
Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian Society of Hematology.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 2, p. 147, doi. 10.1002/ajh.21602
- By:
- Publication type:
- Article
Clinical and economic impact of epoetins in cancer care.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple Myeloma.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.034
- By:
- Publication type:
- Article
Critical concepts, practice recommendations, and research perspectives of pixantrone therapy in non-Hodgkin lymphoma: a SIE, SIES, and GITMO consensus paper.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 6, p. 554, doi. 10.1111/ejh.12768
- By:
- Publication type:
- Article
Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analyzing the decision in different clinical scenarios.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.584541
- By:
- Publication type:
- Article
Clinical and Economic Issues in the Treatment of Advanced Breast Cancer with Bisphosphonates.
- Published in:
- Drugs & Aging, 2003, v. 20, n. 9, p. 631, doi. 10.2165/00002512-200320090-00001
- By:
- Publication type:
- Article
Myelofibrosis with Myeloid Metaplasia following Essential Thrombocythaemia.
- Published in:
- Acta Haematologica, 1989, v. 82, n. 3, p. 150, doi. 10.1159/000205365
- By:
- Publication type:
- Article
Prophylaxis and Treatment of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Results of a Consensus Process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 8, p. 1226, doi. 10.1086/605665
- By:
- Publication type:
- Article
Regulation of erythropoietin production in a case of congenital erythropoietin-dependent pure erythrocytosis.
- Published in:
- American Journal of Hematology, 1994, v. 46, n. 4, p. 348, doi. 10.1002/ajh.2830460417
- By:
- Publication type:
- Article
Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes.
- Published in:
- Genes, 2021, v. 12, n. 8, p. 1271, doi. 10.3390/genes12081271
- By:
- Publication type:
- Article
Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Red cell aplasia in myelofibrosis with myeloid metaplasia. A distinct functional and clinical entity.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression?
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00991-2
- By:
- Publication type:
- Article
Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0225-5
- By:
- Publication type:
- Article
Small-dose iron tolerance test and body iron content in normal subjects.
- Published in:
- European Journal of Haematology, 1991, v. 46, n. 3, p. 152, doi. 10.1111/j.1600-0609.1991.tb01269.x
- By:
- Publication type:
- Article
Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients.
- Published in:
- European Journal of Haematology, 1989, v. 42, n. 4, p. 382, doi. 10.1111/j.1600-0609.1989.tb01229.x
- By:
- Publication type:
- Article
Platelet aggregation in platelet rich plasma and whole blood in 18 patients affected by idiopathic myelofibrosis.
- Published in:
- European Journal of Haematology, 1988, v. 41, n. 3, p. 267, doi. 10.1111/j.1600-0609.1988.tb01191.x
- By:
- Publication type:
- Article
Role of TGF‐β1/miR‐382‐5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2102, doi. 10.1002/1878-0261.12387
- By:
- Publication type:
- Article
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 5, p. 688, doi. 10.1111/bjh.12332
- By:
- Publication type:
- Article
Splenectomy produces a rapid but transient decrease of the frequency of circulating CD34.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 5, p. 665, doi. 10.1111/j.1365-2141.2010.08527.x
- By:
- Publication type:
- Article
A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 446, doi. 10.1111/j.1365-2141.2010.08266.x
- By:
- Publication type:
- Article
A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Anaemia characterises patients with myelofibrosis harbouring Mpl<sup> W515 L/ K</sup> mutation.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 3, p. 244, doi. 10.1111/j.1365-2141.2007.06565.x
- By:
- Publication type:
- Article
research paper Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia.
- Published in:
- British Journal of Haematology, 2004, v. 124, n. 5, p. 618, doi. 10.1111/j.1365-2141.2004.04829.x
- By:
- Publication type:
- Article
Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia.
- Published in:
- British Journal of Haematology, 2001, v. 114, n. 1, p. 78, doi. 10.1046/j.1365-2141.2001.02918.x
- By:
- Publication type:
- Article
VEGFA rs3025039 is associated with phenotype severity of myelofibrosis‐type megakaryocyte dysplasia.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 756, doi. 10.1002/jha2.708
- By:
- Publication type:
- Article
Next‐generation sequencing for BCR‐ABL1 kinase domain mutations in adult patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A position paper.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 9, p. 2960, doi. 10.1002/cam4.2946
- By:
- Publication type:
- Article
New consensus: a unified definition of clinical resistance and/or intolerance to hydroxyurea in essential thrombocythaemia.
- Published in:
- European Journal of Haematology, 2007, v. 79, p. 24, doi. 10.1111/j.1600-0609.2007.00940.x
- By:
- Publication type:
- Article
Myelofibrosis with myeloid metaplasia in adult individuals 30 years old or younger: presenting features, evolution and survival.
- Published in:
- European Journal of Haematology, 2001, v. 66, n. 5, p. 324, doi. 10.1034/j.1600-0609.2001.066005324.x
- By:
- Publication type:
- Article
JAK2 Exon 14 Skipping in Patients with Primary Myelofibrosis: A Minor Splice Variant Modulated by the JAK2-V617F Allele Burden.
- Published in:
- PLoS ONE, 2015, v. 10, n. 1, p. 1, doi. 10.1371/journal.pone.0116636
- By:
- Publication type:
- Article
Enhanced Expression of Stim, Orai, and TRPC Transcripts and Proteins in Endothelial Progenitor Cells Isolated from Patients with Primary Myelofibrosis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091099
- By:
- Publication type:
- Article
<i>JAK2</i> V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059791
- By:
- Publication type:
- Article
Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035631
- By:
- Publication type:
- Article
In Vitro Megakaryocyte Differentiation and Proplatelet Formation in Ph-Negative Classical Myeloproliferative Neoplasms: Distinct Patterns in the Different Clinical Phenotypes.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0021015
- By:
- Publication type:
- Article
High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein Thrombosis.
- Published in:
- PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0015277
- By:
- Publication type:
- Article
Acute limb ischemia in a patient with pre-fibrotic myelofibrosis complicated by heparin-induced thrombocytopenia and thrombosis – case report and systematic review of dabigatran use.
- Published in:
- VASA. Zeitschrift für Gefässkrankheiten, 2021, v. 50, n. 2, p. 151, doi. 10.1024/0301-1526/a000876
- By:
- Publication type:
- Article
Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.
- Published in:
- Current Hematologic Malignancy Reports, 2015, v. 10, n. 4, p. 362, doi. 10.1007/s11899-015-0281-2
- By:
- Publication type:
- Article
An Immune Dysregulation in MPN.
- Published in:
- Current Hematologic Malignancy Reports, 2014, v. 9, n. 4, p. 331, doi. 10.1007/s11899-014-0227-0
- By:
- Publication type:
- Article
Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis.
- Published in:
- Stem Cells, 2016, v. 34, n. 4, p. 1123, doi. 10.1002/stem.2285
- By:
- Publication type:
- Article
Hypermethylation of CXCR4 Promoter in CD34<sup>+</sup> Cells from Patients with Primary Myelofibrosis.
- Published in:
- Stem Cells, 2008, v. 26, n. 8, p. 1920, doi. 10.1634/stemcells.2008-0377
- By:
- Publication type:
- Article
Molecular Profiling of CD34<sup>+</sup> Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (WT1).
- Published in:
- Stem Cells, 2007, v. 25, n. 1, p. 165, doi. 10.1634/stemcells.2006-0351
- By:
- Publication type:
- Article
Everyone is entitled to his or her own opinion but not to their own facts*.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 6, p. 1290, doi. 10.1111/bjh.18035
- By:
- Publication type:
- Article